Clinical trial

Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer

NCT06876636

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2025-03-10

PhaseNA

Study timeline

Study start (actual)2025-03-10Date precision: day

Registry last updated2025-07-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer Metastaticunresolved

Interventions

Zoledronic Acid Combined with Neoadjuvant Chemotherapy (EC-T)DRUG

Sponsors & collaborators

Xijing Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06876636 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.